Related Experiment Video
Updated: Aug 31, 2025
13:07
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
4.0K
Shared decision making in cardiology: a systematic review and meta-analysis
Panagiota Mitropoulou1, Nicolai Grüner-Hegge2, Johannes Reinhold3,4
1Cardiology Department, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Heart (British Cardiac Society)
|August 25, 2022
Summary
Interventions to improve shared decision making (SDM) in cardiology significantly reduce patient decisional conflict and enhance their knowledge. These findings support patient-centered care in cardiology practice.
Area of Science:
- Cardiology
- Health Services Research
- Patient-Centered Care
Background:
- Shared decision making (SDM) is crucial for patient-centered care in cardiology.
- Evaluating interventions that enhance SDM and patient outcomes is essential.
- Decisional conflict and patient knowledge are key indicators of effective SDM.
Approach:
- Systematic review and meta-analysis of randomized controlled trials.
- Searched major electronic databases (Embase, Cochrane, PubMed, Web of Science) up to January 2021.
- Included 18 studies with 4419 patients, focusing on primary outcomes like decisional conflict and secondary outcomes like patient knowledge.
Key Points:
- Interventions to improve SDM significantly reduced decisional conflict (SMD -0.211).
- Interventions also significantly increased patient knowledge (SMD 0.476).
- These effects were observed when compared to standard care.
Conclusions:
- Interventions promoting SDM are effective in cardiology.
- These interventions successfully reduce decisional conflict and improve patient knowledge.
- Wider implementation of SDM interventions is recommended for patient-centered cardiology practice.
Keywords:
meta-analysisMore Related Videos
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
29
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
38
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
38
01:27Coronary Artery Disease V: Interprofessional Care
24
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
24
01:26Atherosclerosis III: Management
26
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
26
01:21Rheumatic Heart Disease III: Medical Management
29
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
29
01:30Heart Failure V: Medical Management
21
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
21